Farallon Capital Management’s Biogen BIIB Stock Holding History

Farallon Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-604,098	Closed	-$172M	–	168
2023 Q2	$172M	Sell	604,098 -15,700	-3%	-$4.67M	0.86%	35
2023 Q1	$172M	Buy	619,798 +27,099	+5%	+$7.5M	0.94%	38
2022 Q4	$164M	Buy	592,699 +287,200	+94%	+$81.1M	0.97%	38
2022 Q3	$81.6M	Buy	305,499 +27,000	+10%	+$5.73M	0.45%	58
2022 Q2	$56.8M	Buy	278,499 +80,700	+41%	+$16.5M	0.31%	69
2022 Q1	$41.7M	Buy	197,799 +50,090	+34%	+$10.9M	0.2%	78
2021 Q4	$35.4M	Sell	147,709 -23,150	-14%	-$5.95M	0.18%	76
2021 Q3	$48.4M	Buy	170,859 +61,859	+57%	+$20.3M	0.23%	77
2021 Q2	$37.7M	Buy	109,000 +6,000	+6%	+$1.82M	0.15%	83
2021 Q1	$28.8M	Hold	103,000	–	–	0.14%	89
2020 Q4	$25.2M	Buy	+103,000	New	+$26.6M	0.15%	85
2018 Q3	–	Sell	-249,000	Closed	-$72.3M	–	103
2018 Q2	$72.3M	Sell	249,000 -91,000	-27%	-$25.6M	0.45%	43
2018 Q1	$93.1M	Sell	340,000 -200,000	-37%	-$62.1M	0.64%	36
2017 Q4	$172M	Buy	540,000 +65,000	+14%	+$20.9M	1.4%	20
2017 Q3	$149M	Buy	475,000 +262,500	+124%	+$77.7M	1.32%	18
2017 Q2	$57.7M	Buy	+212,500	New	+$56.2M	0.6%	34

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Farallon Capital Management's BIIB Position: Q3 2023 in Review

Farallon Capital Management sold out of Biogen (BIIB) in Q3 2023, closing a stake of 604,098 shares — an estimated $172M sold.

Farallon Capital Management first reported a position in BIIB in Q2 2017 and held it in 16 quarters. The position peaked at $172M in Q1 2023. 965 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

Farallon Capital Management reported no remaining Biogen position as of Q3 2023 after selling out during the quarter.
Farallon Capital Management sold 604,098 Biogen shares in Q3 2023, an estimated $172M.
Farallon Capital Management first reported a position in Biogen in Q2 2017 and held it in 16 quarters.
Farallon Capital Management's Biogen position peaked at $172M in Q1 2023.
965 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on Farallon Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.